FDA-cleared profile

Strain AI (SAI001)

Exo Inc

Measures global longitudinal strain from apical four-chamber cardiac ultrasound images in adult patients with suspected disease as an aid to diagnostic analysis; users can accept or reject measurements.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Measures global longitudinal strain from apical four-chamber cardiac ultrasound images in adult patients with suspected disease as an aid to diagnostic analysis; users can accept or reject measurements.
FDA source Exact FDA submission Checked 2026-09-05
Intended users
Clinical end users of a legally marketed ultrasound imaging device into which the Strain AI module is integrated.
FDA source Exact FDA submission Checked 2026-09-05
Care setting and population
Adult
Public source Exact FDA submission Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Workflow role
Post-processing measurement of global longitudinal strain with user acceptance or rejection.
FDA source Exact FDA submission Checked 2026-09-05
Required input
Multi-frame apical four-chamber cardiac ultrasound images from adults with suspected disease. Validation included routine clinical images from cart-based and portable systems at 1.2-4 MHz.
FDA source Exact FDA submission Checked 2026-09-05

The validation frequency range is not a universal compatibility guarantee.

Output and human action
A quantitative global longitudinal strain measurement; end users may accept or reject it.
FDA source Exact FDA submission Checked 2026-09-05
Limitations
No built-in viewer; integration into a legally marketed ultrasound imaging device is required. Patient management must not rely solely on Strain AI analysis.
FDA source Exact FDA submission Checked 2026-09-05

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K242359
FDA source Exact FDA submission Checked 2026-08-31
Modality
Ultrasound
FDA source Exact FDA submission Checked 2026-09-05
Anatomy
Heart/Cardiovascular
FDA source Exact FDA submission Checked 2026-09-05
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2024-11-20
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
A software module integrated by another programmer into a legally marketed ultrasound imaging device; it uses that device's user interface rather than a built-in viewer.
FDA source Exact FDA submission Checked 2026-09-05

The earlier baseline's generic DICOM/PACS claim was not substantiated in this summary. Current Exo Iris interoperability is recorded only as product-family context.

Deployment and data flow
Software package operating on off-the-shelf hardware as an integrated ultrasound-device module.
FDA source Exact FDA submission Checked 2026-09-05
Security and privacy
Vendor documentation pending
Vendor confirmation Exact product version Checked 2026-09-05

No current security attestation or host-specific retention, access and update architecture was established for SAI001.

Training and support
Vendor documentation pending
Vendor confirmation Exact product version Checked 2026-09-05

Host-device onboarding and competency requirements for reviewing or rejecting GLS measurements were not established.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact product version Checked 2026-09-05

No ongoing quality-monitoring service was established. Editorial site questions: test A4C adequacy, rejected measurements and host software updates.

Current Exo Iris interoperability context

The official Iris specifications list DICOM worklist, store and send and PACS/VNA integration. EHR integration requires Exo Works Enterprise; the listed workflow worksheets and 1 TB cloud storage require Exo Works Connect.

product family · checked 2026-09-06

Host-platform package context only; this page does not establish these interfaces for every SAI001 installation.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
Regulatory GLS measurement agreement against a reference device; no independent clinical-outcome comparison was established.
FDA source Exact FDA submission Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-05

GLS agreement is reported; a disease-detection sensitivity with a specified threshold was not established.

Reported specificity
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-05

The reviewed summary does not establish disease-detection specificity.

GLS intraclass correlation coefficient

0.95 ICC

Agreement of A4C global longitudinal strain with reference-device measurements in Held-out routine cardiac ultrasound data from multiple sites, ages 21-96, cart-based and portable systems; sample size unreported.

Tested version: Strain AI (SAI001), K242359

Strain AI K242359 validation performance testing

Standalone measurement-agreement testing on clinical images separated from training, with reference-device ground truth. · Routine cardiac examinations from multiple sites and scanner types; reported age range 21-96.

exact submission · Tested version: Strain AI (SAI001), K242359 · Independence not established

K242359

Us2.v2 is the reference device; ICC and RMSD assess measurement agreement, not disease-detection accuracy. No exact SAI001 publication was established by stored candidate titles.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Research pending
Needs research Exact product version Checked 2026-09-05

A priced SAI001 license or public procurement contract was not reviewed; an Exo Iris bundle price would not establish this module's price.

Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-09-05

No applicable payer policy content was reviewed for this software or strain service.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
18Fields reviewed
9Source classes checked
14Reviewed PubMed leads
0Reviewed trial leads
0Unreviewed FDA recall leads

All 14 stored titles screened and excluded as exact-product evidence: 40055942 is a computer vision syndrome review; the other 13 concern microbiology, microbial strains or veterinary virology. None establishes Exo SAI001 cardiac GLS. No trials were stored. The current discovery snapshot contains 14 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor technical page, literature index, trial registry, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-06.

Alternatives

Related tools to compare

FDA-cleared K213544

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

TOMTEC-ARENA TTA2.50 analyzes ultrasound to quantify and report cardiovascular, fetal, and abdominal structures and functions, including editable AI-assisted echocardiographic...

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2022-01-06
FDA-cleared K201632

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

TOMTEC-ARENA quantifies and reports cardiovascular, fetal, and abdominal structures and functions from supported clinical images and can exchange data with IMAGE-ARENA and...

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2020-08-14